Treatment decisions in oncology are commonly informed by the visual assessment of immunohistochemistry biomarkers by pathologists. However, pathology services face mounting pressure as diagnostic...
There are a number of obstacles confronting today’s clinical trial research field:• Failure to accrue sufficient participants. Protocols designed without the benefit of real...
Introduction - the problem:The emerging field of Computational Medicine encompasses a wide range of technologies at varying levels of maturity with considerable opportunities for...
Idea: Synergy of bioengineers and physicians theoretical and practical work needs start to organization the ORGANOME project - description the Semi-Artificial Human (SemiAO Human)...
